MINK THERAPEUTICS INC. - COMMON STOCK

MiNK Announces Preclinical Data Showcasing Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR 2024

06 3 2024 08:30:00 提供 Nasdaq GlobeNewswire

First Refractory Gastric Cancer Patient Dosed in Phase 2 Trial with Novel Combination of MiNK’s Allogeneic INKT Cell Therapy and Agenus’ Botensilimab and Balstilimab

14 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics' AgenT-797 Shows Promising Results in the Treatment of Severe Acute Respiratory Distress, Published in Nature Communications

06 2 2024 08:00:00 提供 Nasdaq GlobeNewswire

MiNK’s AgenT-797 Offers New Hope in Overcoming ICI Resistance in PD-1 Refractory Gastric Cancer - Published in Oncogene

30 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

ImmunoScape and MiNK Therapeutics Collaborate to Accelerate Novel TCR Identification and Therapeutic Development

20 12 2023 07:30:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics Reports Third Quarter 2023 Results

09 11 2023 07:00:01 提供 Nasdaq GlobeNewswire

MiNK Therapeutics Presents Clinical Activity and Long-Term Persistence of Allogeneic iNKT Cells in Solid Tumors at SITC 2023

03 11 2023 12:00:00 提供 Nasdaq GlobeNewswire

MiNK to Provide Third Quarter 2023 Financial Report and Corporate Update

30 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics To Present Data Update From Allogeneic iNKT Cells in Solid Tumors at SITC 2023

27 9 2023 09:05:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics to Participate in September Investor Conferences

24 8 2023 08:30:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics Reports Second Quarter 2023 Results

10 8 2023 07:30:00 提供 Nasdaq GlobeNewswire

MiNK to Provide Second Quarter 2023 Financial Report and Corporate Update

28 7 2023 08:30:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics Announces Virtual Annual Shareholders Meeting

05 6 2023 07:30:00 提供 Nasdaq GlobeNewswire

MiNK Presents Clinical Data on Allogeneic iNKT Cells (agenT-797) in Severe Respiratory Distress at the American Thoracic Society International Conference

22 5 2023 08:30:00 提供 Nasdaq GlobeNewswire

MiNK's Novel FAP-CAR-iNKT Presented at ASGCT

18 5 2023 08:30:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics Reports Corporate Update and First Quarter 2023 Financial Results

11 5 2023 08:00:02 提供 Nasdaq GlobeNewswire

MiNK Therapeutics to Report First Quarter 2023 Corporate Update and Financial Results

27 4 2023 08:30:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics Announces Clinical Data of Allogeneic iNKT Cells (agenT-797) in Solid Tumor Cancers at the AACR Annual Meeting

18 4 2023 13:32:00 提供 Nasdaq GlobeNewswire

MiNK Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

21 3 2023 08:00:01 提供 Nasdaq GlobeNewswire

MiNK Therapeutics to Present Updated Clinical Data of allo-iNKT Cell Therapy in Solid Tumors at AACR Annual Meeting

15 3 2023 08:45:00 提供 Nasdaq GlobeNewswire